Physician Assistant · Houston, TX
NPI
1043861503
Since 2019
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1515 Holcombe Blvd
Houston, TX, 77030
Phone (713) 792-6161
Groups this clinician bills Medicare through
Medicare paid, 2024
$13K
270 services
Medicare patients, 2024
221
Average age 72
Drug cost, 2024
$3.1M
977 prescriptions
Company payments, 2025
$554
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sara A Carlough was code 38222 (other organ systems), 107 times for 102 patients. In total Sara A Carlough billed 270 services in 10 codes, and Medicare paid $13K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-09-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 38222 Other Organ Systems | Facility | 107 | 102 | $49.17 | $5,261 |
| 99213 Office E&M - Established | Facility | 103 | 84 | $42.74 | $4,402 |
| 99442 Telephone Services | Facility | 25 | 22 | $43.87 | $1,097 |
| 38220 Other Organ Systems | Facility | 15 | 15 | $42.31 | $635 |
By year: 2022 $13K for 291 services; 2023 $18K for 399 services; 2024 $13K for 270 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sara A Carlough prescribed most often to Medicare patients was Valacyclovir (Valacyclovir Hcl), with 142 prescriptions and refills. In total Sara A Carlough wrote 977 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Valacyclovir Valacyclovir Hcl | 142 | 154 | 33 | $3,297 |
| Levofloxacin Generic | 97 | 103 | 28 | $2,262 |
| Allopurinol Generic | 40 | 70 | 17 | $262 |
| Cresemba Isavuconazonium Sulfate | 38 | 44 | 11 | $273K |
| Hydroxyurea Generic | 35 | 60 | 11 | $628 |
| Voriconazole Generic | 29 | 29 | Under 11 | $11K |
| Idhifa Enasidenib Mesylate | 29 | 29 | Under 11 | $936K |
| Acyclovir Generic | 27 | 33 | Under 11 | $552 |
| Promacta Eltrombopag Olamine | 25 | 25 | Under 11 | $822K |
| Potassium Chloride Generic | 22 | 24 | Under 11 | $349 |
| Inqovi Decitabine/Cedazuridine | 21 | 21 | Under 11 | $179K |
| Posaconazole Generic | 20 | 20 | Under 11 | $19K |
| Eliquis Apixaban | 19 | 19 | Under 11 | $11K |
| Prednisone Generic | 18 | 18 | Under 11 | $107 |
| Furosemide Generic | 17 | 26 | Under 11 | $67.29 |
Brand drugs: - claims; generic drugs: 755 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sara A Carlough $554 ($554 in general payments such as food, travel and fees) from 9 companies. The largest payer was Astellas Pharma US Inc with $205.
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc 4503.T | 5 | $205 |
| Syndax Pharmaceuticals, Inc. SNDX | 3 | $90.98 |
| Celgene Corporation BMY | 2 | $62.86 |
| Abbvie Inc. ABBV | 2 | $58.67 |
| Sobi, Inc SOBI.ST | 1 | $34.2 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 1 | $29.79 |
| Genzyme Corporation SNY | 1 | $27.26 |
| Teleflex LLC TFX | 1 | $24.68 |
| Incyte Corporation INCY | 1 | $20.68 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.